TapewireFind a company

person · Reporting owner

Foukas Joshua

Disclosed activity across 1 company

Tapewire entity
48901
SEC CIK
0001748208

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
USANA HEALTH SCIENCES INCUSNA · Entity 6114CHIEF LEGAL OFFICERMay 07, 2026May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

USANA HEALTH SCIENCES INC

Report date May 07, 2026 · Filed May 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2026-05-07 transaction · row 1
1 source row

Row 1 · 2026-05-07 · Sale · Disposed 3,791 · Balance 0

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 26, 2020 Filed Oct 27, 2020 23:01 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 197 $84.06 $16,560.35
Disclosure

SEC source: 0001179110-20-010689 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
October 23, 2020 Filed Oct 27, 2020 23:01 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 315 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-010689 · edgar.xml · derivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,817

Underlying: Common Stock · 315 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

F2 · derivative.expiration_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

Read SEC document
October 23, 2020 Filed Oct 27, 2020 23:01 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 118 $85.86 $10,131.48
Disclosure

SEC source: 0001179110-20-010689 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197

Read SEC document
October 23, 2020 Filed Oct 27, 2020 23:01 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 315 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-010689 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
August 20, 2020 Filed Aug 21, 2020 16:53 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 270 $83.15 $22,451.04
Disclosure

SEC source: 0001179110-20-009212 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
July 23, 2020 Filed Jul 28, 2020 14:57 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 431 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-008500 · edgar.xml · derivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,132

Underlying: Common Stock · 431 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of July 23rd, 2018.

F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of July 23rd, 2018.

Read SEC document
July 23, 2020 Filed Jul 28, 2020 14:57 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 161 $83.36 $13,420.96
Disclosure

SEC source: 0001179110-20-008500 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270

Read SEC document
July 23, 2020 Filed Jul 28, 2020 14:57 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 431 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-008500 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 21:23 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 1,966 $82.49 $162,169.44
Disclosure

SEC source: 0001179110-20-005141 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Weighted average price $82.487. Price range in multiple transactions was $82.45 to $82.49 inclusively.

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 15,000 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · derivative · entry 6

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · derivative · entry 5

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,563

Underlying: Common Stock · 430 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.

F2 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 1,567 $79.00 $123,793.00
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · nonDerivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,966

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 1,567 $70.75 $110,857.42
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 161 $80.71 $12,994.31
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,966

Read SEC document
February 06, 2020 Filed Feb 11, 2020 00:24 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 430 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-001420 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,127

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 05, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 723 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · derivative · entry 10

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,993

Underlying: Common Stock · 723 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018.

F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018.

Read SEC document
February 05, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 299 $78.94 $23,603.06
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 6

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,697

Read SEC document
February 05, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 723 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 5

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 1,019 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · derivative · entry 9

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,716

Underlying: Common Stock · 1,019 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019

F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 1,154 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · derivative · entry 8

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,735

Underlying: Common Stock · 1,154 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019.

F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019.

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 422 $65.93 $27,822.46
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,273

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 1,019 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 478 $65.93 $31,514.54
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 676

Read SEC document
February 04, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 1,154 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 03, 2020 Filed Feb 6, 2020 02:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 GrantRestricted Stock Units · Derivative 8,752 $0.00 $0.00
Disclosure

SEC source: 0001179110-20-001226 · edgar.xml · derivative · entry 7

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,889

Underlying: Common Stock · 8,752 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F5 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020.

F5 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020.

Read SEC document
October 28, 2019 Filed Oct 30, 2019 16:05 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 1,115 $74.53 $83,103.74
Disclosure

SEC source: 0001179110-19-011278 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
October 23, 2019 Filed Oct 25, 2019 21:00 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 316 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-011233 · edgar.xml · derivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,137

Underlying: Common Stock · 316 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

F2 · derivative.expiration_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

Read SEC document
October 23, 2019 Filed Oct 25, 2019 21:00 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 131 $77.92 $10,207.52
Disclosure

SEC source: 0001179110-19-011233 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,115

Read SEC document
October 23, 2019 Filed Oct 25, 2019 21:00 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 316 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-19-011233 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
July 23, 2019 Filed Jul 24, 2019 16:13 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 432 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-008782 · edgar.xml · derivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,453

Underlying: Common Stock · 432 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of July 23rd, 2018.

F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of July 23rd, 2018.

Read SEC document
July 23, 2019 Filed Jul 24, 2019 16:13 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 179 $63.05 $11,285.95
Disclosure

SEC source: 0001179110-19-008782 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 930

Read SEC document
July 23, 2019 Filed Jul 24, 2019 16:13 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 432 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-19-008782 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 06, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 432 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 8

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,885

Underlying: Common Stock · 432 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F5 · derivative.exercise_date: On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.

F5 · derivative.expiration_date: On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.

Read SEC document
February 06, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 179 $102.81 $18,402.99
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · nonDerivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 677

Read SEC document
February 06, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 432 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 05, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 723 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 7

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,317

Underlying: Common Stock · 723 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018.

F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018.

Read SEC document
February 05, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 299 $117.19 $35,039.81
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424

Read SEC document
February 05, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 723 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 723

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
February 04, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 GrantRestricted Stock Units · Derivative 1,569 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 6

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,040

Underlying: Common Stock · 1,569 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019

F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019

Read SEC document
February 04, 2019 Filed Feb 6, 2019 23:22 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 GrantRestricted Stock Units · Derivative 4,614 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 5

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,471

Underlying: Common Stock · 4,614 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019.

F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019.

Read SEC document
October 29, 2018 Filed Oct 31, 2018 20:03 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 291 $111.34 $32,398.89
Disclosure

SEC source: 0001179110-18-012414 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
October 23, 2018 Filed Oct 25, 2018 22:38 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionRestricted Stock Units · Derivative 315 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-012343 · edgar.xml · derivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,857

Underlying: Common Stock · 315 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

F2 · derivative.expiration_date: On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.

Read SEC document
October 23, 2018 Filed Oct 25, 2018 22:38 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Tax withholdingCommon Stock 24 $105.42 $2,530.08
Disclosure

SEC source: 0001179110-18-012343 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291

Read SEC document
October 23, 2018 Filed Oct 25, 2018 22:38 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 315 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-18-012343 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
September 12, 2018 Filed Sep 14, 2018 21:35 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 306 $129.27 $39,557.72
Disclosure

SEC source: 0001179110-18-011433 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 9,848 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · derivative · entry 6

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 9,848 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 4,183 $123.39 $516,132.00
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Weighted average price $123.388. Price range in multiple transactions was $123.00 to $123.825 inclusively.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionCommon Stock 4,183 $70.75 $295,926.34
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 22:51 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 5,152 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · derivative · entry 5

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,848

Underlying: Common Stock · 5,152 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 22:51 UTC USANA HEALTH SCIENCES INC USNA · Entity 6114 SaleCommon Stock 2,348 $130.08 $305,420.80
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 2

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: Weighted average price $130.077. Price range in multiple transactions was $130.00 to $130.55 inclusively.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.